Hoffman’s shift from Microsoft’s board to AI drug discovery highlights a growing trend of tech leaders prioritizing health innovation.
The post Reid Hoffman to leave Microsoft board to focus on AI drug discovery startup Manas AI appeared first on Crypto Briefing.